Les meilleurs oncologues en en Israël - TOP-112 des médecins

Le Dr Pelles Sharon dirige l'Institut des tumeurs gastro-intestinales d'Israël au centre médical Sourasky, se spécialisant dans les cancers digestifs complexes avec des traitements innovants comme la HIPEC.

• Formée au prestigieux Royal Marsden Cancer Centre de Londres
• Spécialisée dans les interventions de Whipple et les thérapies ciblées sur le foie
• Pionnière de la recherche sur la participation des patients aux essais cliniques
• Offre des soins complets, de la chirurgie à l'immunothérapie

Investigateur principal d'essais cliniques dans les thérapies contre le cancer – le Dr Sarid apporte des traitements de pointe au centre médical Sourasky.

• Plus de 15 ans en tant qu'oncologue senior à Sourasky (Ichilov)
• Spécialisé en chimiothérapie, radiothérapie et thérapies biologiques
• A publié plus de 30 articles sur le traitement du cancer
• Chargé de cours à l'Université de Tel Aviv
• Membre de l'ESMO et de l'ASCO

Le professeur Ofer Merimsky dirige l'unité d'oncologie des tissus mous et des os du centre médical Sourasky – le plus grand spécialiste israélien des sarcomes, formé à Paris.

• Plus de 25 ans de spécialisation dans les sarcomes des os et des tissus mous
• Membre de la faculté de l'ESMO pour les protocoles de traitement des sarcomes
• Auteur de nombreuses publications sur l'immunologie des tumeurs et l'oncologie orthopédique
• Ancien président de la Société israélienne d'oncologie et de radiothérapie
• Développe des approches innovantes en matière de radiothérapie et d'immunothérapie

Plus de 1 100 traitements oncologiques réalisés – Le Dr Sapra est spécialisée dans les cancers gynécologiques et la radiothérapie au Sourasky Medical Center, classé parmi les 5 meilleurs hôpitaux par Forbes.

• Double spécialisation en gynécologie oncologique et en radiothérapie
• Plus de 30 ans d'expérience dans les cancers de l'appareil reproducteur féminin
• Membre de la faculté de l'Université de Tel Aviv
• Membre des sociétés savantes SGO et ASCO

Certifié à la fois en médecine interne et en cardiologie, le Dr Aballay possède plus de 20 ans d'expérience dans le traitement de conditions médicales complexes.

• Spécialisé en cardiologie, pneumologie et médecine de soins intensifs
• Fournit des soins complets au centre médical Sourasky à Tel Aviv
• Maîtrise l'anglais et l'espagnol pour une communication claire

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Shira Felder is a senior radiation oncologist. She focuses on gynecologic and urologic cancers. She has advanced expertise in VMAT, IMRT, SBRT, and gynecologic brachytherapy. She delivers precise treatment with fewer side effects.

She heads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior physician in the Radiation Oncology Division. She earned her MD at Hadassah. She completed residency at Sheba and a fellowship in the Radiation Medicine Program at the University of Toronto and Princess Margaret Cancer Centre. She is board-certified in Radiation Oncology. She is a member of ESTRO, the Israeli oncology societies, the CPSO, and the CMA.

Her research covers brachytherapy patient safety. It also includes stereotactic ablative radiotherapy for stage I lung cancer. She has studied treatment delays in cervical cancer. She has examined vitamin D deficiency in oncology patients.

Professor Dov Zippel is a general surgeon and surgical oncologist. He specializes in breast disease and melanoma. He leads the Meirav Breast Center at Sheba Medical Center. He also serves at the Ella Lemelbaum Institute for Immuno-Oncology. In 2025, Forbes Israel named him to its Best Doctors list.

Expertise: advanced care for benign and malignant breast tumors. Minimally invasive and breast-conserving surgery. Surgical treatment of melanoma and other skin cancers.

Accreditations: MD, Tel Aviv University. Residency in general surgery, Sheba Medical Center. Fellowship in surgical oncology, University of Calgary. Board-certified in general surgery and surgical oncology. Research includes intact breast lesion excision and perioperative BRAF inhibitors for stage III melanoma.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Le Dr Ari Raphael dirige l'Initiative nationale de médecine génomique d'Israël au centre médical Sourasky, pionnier des traitements d'oncologie de précision.

• Maître de conférences avec des recherches approfondies en génomique et en informatique biomédicale
• Investigateur principal pour de multiples essais cliniques sur le cancer du poumon et du sein
• Expert en biopsies liquides et en profilage génomique complet
• Modérateur du conseil moléculaire des tumeurs de la Société israélienne du cancer du poumon
• Membre de l'ESMO et de l'IASLC avec une formation internationale

Dirige la division d'oncologie médicale du centre médical Sourasky – l'un des principaux hôpitaux d'Israël, spécialisé dans les cas de cancer complexes.

• Plus de 20 ans d'expérience en oncologie et en médecine interne
• Spécialisé dans les cancers gastro-intestinaux, du foie et du pancréas
• Expert en protocoles avancés de chimiothérapie et d'immunothérapie
• Parle couramment l'anglais pour une communication claire avec les patients internationaux

Plus de 900 traitements contre le cancer du cerveau effectués – Le Dr Blumental dirige le service de neuro-oncologie du centre médical Sourasky.

• Formée au Memorial Sloan-Kettering Cancer Center – un leader mondial des soins contre le cancer
• Ancienne directrice de la neuro-oncologie au Huntsman Cancer Institute
• Spécialisée dans les cas complexes comme le glioblastome et le méningiome
• Forbes Israël l'a reconnue comme l'un des meilleurs médecins du pays

Chef de la clinique de neuro-oncologie du centre médical Sourasky – Le Dr Bokstein dirige une équipe spécialisée se concentrant exclusivement sur les tumeurs complexes du cerveau et de la moelle épinière.

• Expert en traitements de précision tels que la protonthérapie et la radiochirurgie Gamma Knife
• Intègre la chimiothérapie, les thérapies ciblées et les options d'essais cliniques dans les plans de traitement
• Membre d'associations de neuro-oncologie américaines, européennes et israéliennes
• Conférencier et auteur sur la neuro-oncologie à l'Université de Tel Aviv